The “Dolo case” appears as a small manifestation of a much larger problem, underlining the urgent need for a comprehensive and effective regulation of the pharmaceutical industry and private healthcare sector in public interest.
October 1, 2022
Posted in: DPS Topics ,
Tags: Dolo Case , Polity ,